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Abstract
Background: Studies have linked the natural history of many pathologies with environmen-
tal physical activity. This study investigated the relationship between the occurrence of ven-
tricular tachycardia/fibrillation (VT/VF) recorded by implantable cardioverter defibrillators
(ICD) and geomagnetic and cosmic ray (neutron) activity.
Methods: The study group included 85 patients (73 men) with cardiomyopathy (80% ische-
mic) who underwent ICD placement in the years 1995–2006; 74% had a left ventricular
ejection fraction of < 30%. Data on the days on which VT/VF occurred (total number of days:
284) and the days on which the patients were treated (total number of treatments: 580) were
collected from the ICD records. The findings were analyzed against levels of geomagnetic
activity (GMA) (Io–IVo) and cosmic ray activity (CRA), derived from international observato-
ries, on the same days and throughout the study period.
Results: On days of VT/VF, daily values of GMA level averaged 1.5 ± 0.7, consistent with
level Io (quiet). The ratios of daily VT/VF episodes and treatment to GMA level for the whole
study period were as follows: 1.2 level I; 0.9 level II; 0.69 level III; 0.78 level IV (r = –0.974;
p = 0.02). Mean CRA on days of VT/VF was 9246.8 ± 299.0 imp/min, and for all 4383 days
studied, 8805.33 ± 411.4 imp/min (p < 0.0001).
Conclusions: In patients with predominantly ischemic cardiomyopathy and severe left ven-
tricular dysfunction, VT/VF occurs more often on days of low GMA and high CRA. Further
studies are needed to determine the underlying mechanism of the effect of neutron activity on
cardiac electrical instability. (Cardiol J 2008; 15: 437–440)
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Introduction
Sudden cardiac death (SCD) remains a funda-
mental problem in cardiology [1]. In the individual
patient, SCD tends to occur in close proximity to
the occurrence of life-threatening cardiac arrhyth-
mia; the most frequent triggers are ventricular ta-
chycardia (VT) and ventricular fibrillation (VF) [1].
Studies have reported an apparent link between the
risk of SCD and levels of certain environmental
physical factors [2–5]. Given the current ability of
clinicians, and thanks to recent technological advan-
ces that allow us to more precisely fix the time of
arrhythmia preceding SCD, we sought to analyze the
time of occurrence of VT and VF, as recorded by
implantable cardioverter defibrillators (ICD), against
concomitant daily geomagnetic activity (GMA) and
cosmic ray activity (CRA) in order to further our
understanding of the cosmobiology of SCD.
Methods
The study group included 85 patients, 73 men
(85.9%) and 12 women, who underwent placement
of an ICD between 1995 and 2006. All had ischemic
(80%) or other forms of cardiomyopathy accompa-
nied by life-threatening cardiac arrhythmia. Mean
(±SD) patient age was 69.35 ± 11.37 years; for
men, 70.15 ± 11.33 years (median 73, range 36–
–86) and for women, 64.77 ± 13.63 years (median
62, range 36–81). For patients without ischemic
cardiomyopathy (ICM) the age was 52.55 ± 11.6
(median 51, range 36–71).
In 63 patients (74%), left ventricular ejection
fraction was less than 30%. The mean observation
time per patient from ICD implantation to last VT/VF
event was 3.33 ± 2.27 years (median 3, range 1–12).
Among the patients with ICM, 61 (89.7%) suf-
fered acute myocardial infarction (AMI), 10 (14.7%)
multiple myocardial infarction, in the past;
34 (50.00%) patients previously underwent corona-
ry artery bypass grafting (CABG), 4 repeatedly, and
5 also had valve replacement and 6 had surgery for
cardiac aneurysm. All these events took place more
than 10–15 years before the patients were treated
by ICD. Twelve (14.2%) also suffered from chronic
renal failure (CRF), part treated by hemodialysis.
Nine patients had chronic or paroxysmal atrial fi-
brillation. Nine patients (10.5%) were treated by
cardiac resynchronization therapy, biventricular pa-
cing for congestive heart failure (CHF). Three ad-
ditional patients had pacemakers for heart conduc-
tion problems. Concomitant factors like such as
hyperlipidemia, arterial hypertension, diabetes mel-
litus and smoking in the past were accompanied the
natural history of most of these patients, as is often
the case in ICM.
Nine (10.5%) patients had thyroid problems as
a complication of long amiodaron (Procor) use. In
addition, two patients were diagnosed with Procor
lungs.
As well as this drug, patients were treated with
statins for hyperlipidemia, antiplatelet drugs, angio-
tensin converting enzyme (ACE) inhibitors, angio-
tensin receptor blocker (ARB), aldosterone antago-
nists and by CHF, diuretics, carvedilol and less fre-
quent by other beta-blockers for heart failure.
Among our patients, 7 (8.2%) underwent abor-
ted SCD and 8 (9.4%) had repeated syncope.
For the present study, ICD data were collec-
ted for each patient for the entire observation pe-
riod (4383 days) and for the days on which VT/VF
was recorded by ICD and treated. GMA and CRA
values on the same days, and throughout the study
period, were derived from international observato-
ries: United States Air Force National Geophysical
and Space Weather Prediction Centers [6–8], Izmi-
ran Institute of the Russian Academy of Sciences
[9], and Oulu University Neutron Monitoring Sta-
tion [10]. GMA was measured using Ap., Cp., Am
indices, by level (Table 1), and CRA was calculated
from measurements of neutron activity on the
Earth’s surface in impulses/minute.
Statistical analysis
Pearson correlation coefficients (r) and their
probabilities and Student’s t-test were used to ana-
lyze comparative data. P values of 95% and higher
were considered significant, and values of 90–94%
as strong trends toward statistical significance.
Table 1. Geomagnetic activity gradation.
Category “A” index Typical “K” Amplitude
range  values (nanotesla)
Quiet 0 < A < 8 Usually 0–20
(Io) No. > 3
Unsettled 8 < A < 16 Usually 21–40
(IIo) No. > 3
Active 16 < A < 30 Few indices 41–70
(IIIo) of 4
Minor 30 < A < 50 Mostly 71–120
storm (IVo) 4 and 5
Major 50 < A < 100 Some 121–200
storm (IVo) indices 6
Severe 100 < A Some 201– > 550
storm (IVo) indices 7
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Results
Episodes of VT/VF were recorded on a total of
284 days during the observation period, and a total
of 580 treatments were administered by the defi-
brillators.
On days of VT/VF, the daily values of GMA
level averaged 1.5 ± 0.7, consistent with level I
(quiet). Figure 1 presents the inverse correlation
between levels of GMA and VT/VF occurrence
(r = –0.974, p = 0.02). By contrast, as shown in
Figure 2, for the whole observation period (4383 days)
neutron activity was significantly higher on days of
VT/VF (p < 0.0001). Indices of GMA for 1990–2006
were strongly and inversely correlated with CRA:
r = –0.55, p < 0.0001; solar activity indices also
showed a similar relationship with CRA: r = –0.75,
p < 0.0001.
Discussion
Studies conducted in the last 15 years have
demonstrated an apparent association of the occur-
rence of cardiac arrhythmias and SCD with chan-
ging levels of geomagnetic and cosmic ray (neutron)
activity [2–5, 10, 11]. Using 24-hour Holter moni-
toring, we previously showed that more atrial and
ventricular premature contractions occurred on
days of lowest Io (quiet) GMA than on days of hi-
gher GMA [10]. Similar data were noted for ventri-
cular tachycardia [12]. The findings for paroxysmal
atrial fibrillation were confirmed in a separate stu-
dy [13]. A recent study of ICD discharges in respon-
se to VF in patients meeting the criteria of the
Multicenter Automatic Defibrillator Implantation
Trial II (MADITT II) showed that ventricular extra-
systoles were the basic trigger of VF [14].
Investigations of SCDs specifically revealed
that SCDs occurring within 3 hours of life-threate-
ning arrhythmia occurred more often on days of low
GMA [2]. These findings were supported by additio-
nal studies conducted in different geographic areas
wherein days of lowest GMA were found to be cha-
racterized by more SCDs within one hour of onset of
symptoms in men aged more than 65 years and fe-
wer deaths within 1–24 hours of symptoms in women
aged more than 65 years [3]. The rate of occurrence
of early SCDs (within one hour of symptoms) decre-
ased as daily GMA levels increased [5]. Similar fin-
dings were noted for acute myocardial infarction [15].
The results of the present study confirm our
early report of the relationship between ICD di-
scharges and low GMA [16]. In response to criti-
ques that our initial findings may have been coinci-
dental [17], we included a much larger sample over
a longer term and measured both GMA and CRA
simultaneously. We noted higher CRA on days of
VF/VT, in agreement with other studies reporting
greater activity on days of ICD discharges [18] and
on days of SCDs related to AMI [15, 19]. In addi-
tion, a post-mortem study of 780 patients found an
association between CRA and death due to myocar-
dial rupture, repeated AMI and coronary thrombo-
sis with SCD preceding AMI [4].
Figure 1. Geomagnetic activity level (I–IV) on days (n = 284)
of implantable cardioverter-defibrillator (ICD) treatments
of ventricular tachycardia/ventricular fibrillation.
Figure 2. Cosmic ray activity (neutron activity) in imp/
/min on days of implantable cardioverter-defibrillator
(ICD) treatments (n = 284) for ventricular tachycardia/
/ventricular fibrillation compared to the average during
the whole observation period 1995–2006 (4383 days).
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We presume that higher CRA, which occurs at
times of lower GMA and lower solar activity [20],
contributes to electrical heart instability, especial-
ly in patients with damaged heart muscles as a con-
sequence of repeated AMI or ischemic cardiomy-
opathy, as in our series. We presume that neutrons
bind to the H+ that is readily available in tissue
lipids, forming protons that disturb normal tissue
functioning. This activity is highly damaging to the
nuclei of cells already damaged by ischemia or in-
farction, as shown in radiotherapy studies [21]. The
changes are accompanied by electrical heart insta-
bility, conduction asynchrony, extrasystole, VT,
and VF [2–5, 14, 16, 18, 19].
These findings should form the basis of further
studies to determine if artificial magnetic fields can
shield patients with ICDs from life-threatening ar-
rhythmias (with consideration of its possibly dama-
ging effect on the device and potential effects on
coagulation and inflammation markers) [11, 22]. It
should be noted that treatment by magnetic fields
is already being used for patients with severe de-
pression [23, 24].
Limitations of the study
The majority of patients in the present study
were male and had ischemic cardiomyopathy. Stu-
dies have shown that ICD function differs in women
and in patients with other types of cardiomyopathy/
/heart muscle pathologies [25], so inclusion of a more
varied range of patients would provide additional
information.
Conclusions
Implantable cardioverter defibrillator recor-
dings and treatment of episodes of VT/VF appear
to be inversely correlated with the daily level of
GMA and directly correlated with CRA (as measu-
red by neutron fluctuations). Studies are needed to
determine the underlying mechanism of the possi-
ble arrhythmogenic effect of physical environmen-
tal changes.
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